Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin.

AUTOR(ES)

Chou, C K

RESUMO

The effects of somatostatin (SRIF), insulin, and triiodothyronine (T3) on the growth of human hepatoma cells were investigated on the well-differentiated human hepatoma cell line Hep3B. Results showed that both insulin and T3 can stimulate cell growth of serum starved Hep3B cells at physiological concentrations. SRIF alone showed little growth-promoting activity. When added concurrently with insulin, however, SRIF suppressed the insulin-induced cell proliferation in a dose-dependent manner. On the other hand, SRIF had no inhibitory effect on T3-induced cell proliferation. SRIF is labile in the medium, with a half-life of about 2 h during culture incubation. SRIF did not disturb the insulin binding to its surface receptors nor inhibit the insulin-dependent receptor kinase activity of Hep3B cells in vitro. These results suggest that postreceptor regulation may be involved. The selective suppression by SRIF of insulin-induced cell growth provides an unique approach to the study of insulin actions on proliferation of human hepatoma cells.

Documentos Relacionados

• Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation.
• Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation.
• Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.
• Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
• Insulin-induced hypoglycaemia does not abolish chorea.